These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 23731763)

  • 41. Review of Dohan Eherenfest et al. (2009) on "Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)".
    Marín Fermín T; Calcei JG; Della Vedova F; Martinez Cano JP; Arias Calderon C; Imam MA; Khoury M; Laupheimer MW; D'Hooghe P
    J ISAKOS; 2024 Apr; 9(2):215-220. PubMed ID: 37562572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue.
    Chieregato K; Castegnaro S; Madeo D; Astori G; Pegoraro M; Rodeghiero F
    Cytotherapy; 2011 Sep; 13(8):933-43. PubMed ID: 21623669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism.
    Dohan Ehrenfest DM; Bielecki T; Del Corso M; Inchingolo F; Sammartino G
    J Biomed Mater Res A; 2010 Dec; 95(4):1280-2. PubMed ID: 20925082
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative release of growth factors from PRP, PRF, and advanced-PRF.
    Kobayashi E; Flückiger L; Fujioka-Kobayashi M; Sawada K; Sculean A; Schaller B; Miron RJ
    Clin Oral Investig; 2016 Dec; 20(9):2353-2360. PubMed ID: 26809431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controlled delivery of platelet-rich plasma-derived growth factors for bone formation.
    Lu HH; Vo JM; Chin HS; Lin J; Cozin M; Tsay R; Eisig S; Landesberg R
    J Biomed Mater Res A; 2008 Sep; 86(4):1128-36. PubMed ID: 18181109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of autogenous growth factors on heterotopic bone formation of osteogenic cells in small animal model.
    Arpornmaeklong P; Pripatnanont P; Kittidumkerng W; Mitarnun W
    J Craniomaxillofac Surg; 2012 Jun; 40(4):332-40. PubMed ID: 21724408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of Growth Factors, Cytokines, and Chemokines in Bone Marrow Concentrate and Platelet-Rich Plasma: A Prospective Analysis.
    Ziegler CG; Van Sloun R; Gonzalez S; Whitney KE; DePhillipo NN; Kennedy MI; Dornan GJ; Evans TA; Huard J; LaPrade RF
    Am J Sports Med; 2019 Jul; 47(9):2174-2187. PubMed ID: 31034242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteogenic differentiation of muscle satellite cells induced by platelet-rich plasma encapsulated in three-dimensional alginate scaffold.
    Huang S; Jia S; Liu G; Fang D; Zhang D
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5 Suppl):S32-40. PubMed ID: 23083953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled release of PRP-derived growth factors promotes osteogenic differentiation of human mesenchymal stem cells.
    Lin SS; Landesberg R; Chin HS; Lin J; Eisig SB; Lu HH
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():4358-61. PubMed ID: 17947081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of short-term cryopreservation on the properties and functionality of platelet-rich plasma.
    Beitia M; Delgado D; Mercader J; Gimeno I; Espregueira-Mendes J; Aizpurua B; Sánchez M
    Platelets; 2023 Dec; 34(1):2210243. PubMed ID: 37165543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet-rich preparations to improve healing. Part II: platelet activation and enrichment, leukocyte inclusion, and other selection criteria.
    Davis VL; Abukabda AB; Radio NM; Witt-Enderby PA; Clafshenkel WP; Cairone JV; Rutkowski JL
    J Oral Implantol; 2014 Aug; 40(4):511-21. PubMed ID: 25106017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Facilitated recruitment of mesenchymal stromal cells by bone marrow concentrate and platelet rich plasma.
    Holmes HL; Wilson B; Goerger JP; Silverberg JL; Cohen I; Zipfel WR; Fortier LA
    PLoS One; 2018; 13(3):e0194567. PubMed ID: 29566102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination.
    Dallari D; Fini M; Stagni C; Torricelli P; Nicoli Aldini N; Giavaresi G; Cenni E; Baldini N; Cenacchi A; Bassi A; Giardino R; Fornasari PM; Giunti A
    J Orthop Res; 2006 May; 24(5):877-88. PubMed ID: 16609976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties.
    El-Sharkawy H; Kantarci A; Deady J; Hasturk H; Liu H; Alshahat M; Van Dyke TE
    J Periodontol; 2007 Apr; 78(4):661-9. PubMed ID: 17397313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apheresis Platelet Rich-Plasma for Regenerative Medicine: An In Vitro Study on Osteogenic Potential.
    Pulcini S; Merolle L; Marraccini C; Quartieri E; Mori D; Schiroli D; Berni P; Iotti B; Di Bartolomeo E; Baricchi R; Sala R; Pertinhez TA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445472
    [No Abstract]   [Full Text] [Related]  

  • 56. Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells.
    Viau S; Chabrand L; Eap S; Lorant J; Rouger K; Goudaliez F; Sumian C; Delorme B
    PLoS One; 2017; 12(8):e0181406. PubMed ID: 28763452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics.
    Vogel JP; Szalay K; Geiger F; Kramer M; Richter W; Kasten P
    Platelets; 2006 Nov; 17(7):462-9. PubMed ID: 17074722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Properties of osteoconductive biomaterials: calcium phosphate cement with different ratios of platelet-rich plasma as identifiers.
    Ko CL; Chen WC; Chen JC; Wang YH; Shih CJ; Tyan YC; Hung CC; Wang JC
    Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3537-44. PubMed ID: 23706244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneity in amount of growth factors secreted by platelets in platelet-rich plasma samples from alopecia patients.
    Shaik JA; Estharabadi N; Farah RS; Hordinsky MK
    Exp Dermatol; 2020 Oct; 29(10):1004-1011. PubMed ID: 32748436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures.
    Mojica-Henshaw MP; Jacobson P; Morris J; Kelley L; Pierce J; Boyer M; Reems JA
    Cytotherapy; 2013 Dec; 15(12):1458-68. PubMed ID: 24199591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.